News - Cardio-vascular, MedImmune

Filter

Current filters:

Cardio-vascularMedImmune

Popular Filters

AstraZeneca's Brilinta gains Class I in ACCF/AHA Guidelines; enters deal with Progenics

18-12-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced yesterday that a combined panel of experts…

Antibiotics and Infectious diseasesAstraZenecaBrilintaCardio-vascularLicensingMedImmunePharmaceuticalProgenics PharmaceuticalsRegulation

Back to top